| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 68 |
| 1 | GEMCITABINE HYDROCHLORIDE | 28 |
| 2 | GEMCITABINE | 25 |
| 3 | FLUOROURACIL | 24 |
| 4 | FLUOROURACIL CREAM, 0.5% | 24 |
| 5 | SITAGLIPTIN | 22 |
| 6 | PACLITAXEL | 19 |
| 7 | OXALIPLATIN | 17 |
| 8 | LANSOPRAZOLE | 13 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PACKERA AUREA | 1 | 0.5000 |
| 1 | SENNA 8.6MG | 1 | 0.0185 |
| 2 | ACID REDUCER | 1 | 0.0039 |
| 3 | FAMOTIDINE 20MG | 1 | 0.0027 |
| 4 | PANCRELIPASE | 68 | 0.0017 |
| 5 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 6 | METYRAPONE | 1 | 0.0010 |
| 7 | ALDESLEUKIN | 1 | 0.0008 |
| 8 | ETHIODIZED OIL | 1 | 0.0008 |
| 9 | PSYLLIUM HUSK | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 27 |
| 1 | Microtubule Inhibitor [EPC] | 21 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Platinum-based Drug [EPC] | 20 |
| 4 | Proton Pump Inhibitor [EPC] | 18 |
| 5 | GLP-1 Receptor Agonist [EPC] | 14 |
| 6 | Insulin Analog [EPC] | 12 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 12 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Opioid Agonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 6 | Cannabinoid [EPC] | 2 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 8 | Phenothiazine [EPC] | 7 | 0.0002 |
| 9 | Bile Acid [EPC] | 5 | 0.0002 |